{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.168","meta":{"versionId":"23","lastUpdated":"2021-03-14T06:43:50.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.168","version":"20210314","name":"Doxorubicin Injectable","status":"active","date":"2021-03-14T06:43:50-04:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"1191138","display":"doxorubicin hydrochloride 2 MG/ML Injectable Solution"},{"code":"1790095","display":"doxorubicin hydrochloride 50 MG Injection"},{"code":"1790097","display":"5 ML doxorubicin hydrochloride 2 MG/ML Injection"},{"code":"1790099","display":"10 ML doxorubicin hydrochloride 2 MG/ML Injection"},{"code":"1790100","display":"25 ML doxorubicin hydrochloride 2 MG/ML Injection"},{"code":"1790103","display":"doxorubicin hydrochloride 10 MG Injection"}]}]}}